SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-072728
Filing Date
2023-03-16
Accepted
2023-03-16 17:09:18
Documents
15
Period of Report
2023-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d445048d8k.htm   iXBRL 8-K 28115
2 EX-99.1 d445048dex991.htm EX-99.1 79973
7 GRAPHIC g445048gra006a.jpg GRAPHIC 3017
  Complete submission text file 0001193125-23-072728.txt   289488

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cmra-20230316.xsd EX-101.SCH 3931
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmra-20230316_def.xml EX-101.DEF 14503
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmra-20230316_lab.xml EX-101.LAB 24070
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmra-20230316_pre.xml EX-101.PRE 15601
9 EXTRACTED XBRL INSTANCE DOCUMENT d445048d8k_htm.xml XML 5395
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 23739713
SIC: 2834 Pharmaceutical Preparations